STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $253,000 | +283.3% | 23,324 | +63.9% | 0.06% | +510.0% |
| Q1 2016 | $66,000 | -84.1% | 14,229 | -78.4% | 0.01% | -77.8% |
| Q4 2015 | $416,000 | +26.1% | 65,957 | +76.5% | 0.04% | +40.6% |
| Q3 2015 | $330,000 | -78.4% | 37,372 | -71.2% | 0.03% | -78.5% |
| Q2 2015 | $1,530,000 | -59.3% | 129,974 | -50.0% | 0.15% | -59.5% |
| Q1 2015 | $3,761,000 | +297.1% | 259,916 | +368.3% | 0.37% | +308.9% |
| Q4 2014 | $947,000 | -36.7% | 55,507 | -53.8% | 0.09% | -30.8% |
| Q3 2014 | $1,497,000 | +224.7% | 120,112 | +282.2% | 0.13% | +261.1% |
| Q2 2014 | $461,000 | +68.2% | 31,427 | +419.7% | 0.04% | +200.0% |
| Q3 2013 | $274,000 | – | 6,047 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |